文献速递胃肠动力与功能性疾病

系统综述与荟萃分析:肠易激综合征患者焦虑和抑郁的患病率

Systematic review with meta-analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome.
PubMed 文献 · Aliment Pharmacol Ther · 2019-06-03

该研究系统检索截至2019年1月1日的Embase、PubMed、Scopus、Web of Science和POPLINE数据库,纳入73篇报告成人(≥15岁)肠易激综合征(IBS)患者焦虑/抑郁症状或障碍患病率的研究。IBS患者焦虑症状和焦虑障碍的患病率粗合并估计分别为39.1%(95%CI:32.4-45.8)和23%(95%CI:17.2-28.8),抑郁症状和抑郁障碍的患病率分别为28.8%(95%CI:23.6-34)和23.3%(95%CI:17.2-29.4);与健康对照相比,IBS患者焦虑或抑郁的OR约为三倍。

要点

  • IBS患者焦虑症状患病率为39.1%,焦虑障碍为23%。
  • IBS患者抑郁症状患病率为28.8%,抑郁障碍为23.3%。
  • 与健康对照相比,IBS患者焦虑或抑郁的OR约为三倍。

核心结论

  • 与健康对照相比,IBS患者焦虑或抑郁的OR约为三倍。

研究设计与样本

  • 系统综述与荟萃分析,检索Embase、PubMed、Scopus、Web of Science和POPLINE数据库截至2019年1月1日的文献,无语言限制,最终纳入73篇报告成人(≥15岁)IBS患者焦虑/抑郁症状或障碍患病率的研究,采用Stata软件计算合并患病率、OR及95%CI。

主要发现

  • IBS患者焦虑症状患病率为39.1%(95%CI:32.4-45.8),焦虑障碍患病率为23%(95%CI:17.2-28.8)。
  • 与健康对照相比,IBS患者焦虑症状的OR为3.11(95%CI:2.43-3.98),焦虑障碍的OR为2.52(95%CI:1.99-3.20)。
  • IBS患者抑郁症状患病率为28.8%(95%CI:23.6-34),抑郁障碍患病率为23.3%(95%CI:17.2-29.4)。
  • 与健康对照相比,IBS患者抑郁症状的OR为3.04(95%CI:2.37-3.91),抑郁障碍的OR为2.72(95%CI:2.45-3.02)。

临床怎么用

  • 在消化内科评估IBS患者时,可关注其焦虑和抑郁症状或障碍的患病情况。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Irritable bowel syndrome (IBS) is a common and potential disabling functional gastrointestinal disorder. Studies have revealed a possible association between IBS and psychological problems, such as anxiety and depression. Existing systematic reviews have addressed only the levels of anxiety or depression in patients with IBS. AIM: To investigate systematically the prevalence of anxiety or depression in IBS patients METHODS: A literature search was conducted using the related keywords from the bibliographic databases of Embase, PubMed, Scopus, Web of Science and POPLINE published until 1 January 2019 with no language restriction. Studies reporting the prevalence of anxiety/depressive symptoms/disorders in adult (≥15 years) IBS patients were evaluated. The pooled prevalence, odds ratio (OR) and 95% CI were calculated using stata software. RESULTS: A total of 14 926 articles were initially screened, and finally 73 papers were included. The prevalence rates of anxiety symptoms and disorders in IBS patients were 39.1% (95% CI: 32.4-45.8) and 23% (95% CI: 17.2-28.8) respectively. The ORs for anxiety symptoms and disorders in IBS patients compared with healthy subjects were 3.11 (95% CI: 2.43-3.98) and 2.52 (95% CI: 1.99-3.20) respectively. The prevalence estimates of depressive symptoms and disorders in IBS patients were 28.8% (95% CI: 23.6-34) and 23.3% (95% CI: 17.2-29.4) respectively. The ORs for depressive symptoms and disorders in IBS patients compared to healthy subjects were 3.04 (95% CI: 2.37-3.91) and 2.72 (95% CI: 2.45-3.02) respectively. CONCLUSION: Patients with IBS have a three-fold increased odds of either anxiety or depression, compared to healthy subjects.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Zamani M, Alizadeh-Tabari S, Zamani V, et al. Systematic review with meta-analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome. Aliment Pharmacol Ther. 2019. PMID: 31157418. doi:10.1111/apt.15325

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。